Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Howe

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Surgical Oncology Clinics of North America|November 28, 2015
Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine TumorsJessica E Maxwell, Thomas M O'Dorisio, James R Howe
Annual Review of Medicine|October 20, 2021
Progress in the Management of Pancreatic Neuroendocrine TumorsAmy Chang, Scott K Sherman, James R Howe, et al.
Neuroscience|November 28, 2002
The expression of dominant-negative subunits selectively suppresses neuronal AMPA and kainate receptorsAntoine Robert, Rhonda Hyde, Thomas E Hughes, et al.
Biophysical Journal|May 30, 2006
The relationship between agonist potency and AMPA receptor kineticsWei Zhang, Antoine Robert, Stine B Vogensen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2005
AMPA receptor binding cleft mutations that alter affinity, efficacy, and recovery from desensitizationAntoine Robert, Neali Armstrong, J Eric Gouaux, et al.
The European Journal of Neuroscience|March 22, 2002
The speeding of EPSC kinetics during maturation of a central synapseMark J Wall, Antoine Robert, James R Howe, et al.
Current Treatment Options in Oncology|October 13, 2025
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine TumorsJeremy Chang, Udhayvir S Grewal, Scott K Sherman, et al.
Hematology/Oncology Clinics of North America|November 7, 2024
Surgical Management of Neuroendocrine Tumor Liver MetastasesCatherine G Tran, Scott K Sherman, Chandrikha Chandrasekharan, et al.
Current Problems in Surgery|May 19, 2005
Hereditary colorectal cancer-part IIAnders Merg, Henry T Lynch, Jane F Lynch, et al.
The Journal of Surgical Research|February 10, 2012
Germline mutations in SMAD4 disrupt bone morphogenetic protein signalingJennifer C Carr, Fadi S Dahdaleh, Donghong Wang, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Surgical Oncology Clinics of North America|November 28, 2015
Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine TumorsJessica E Maxwell, Thomas M O'Dorisio, James R Howe
Annual Review of Medicine|October 20, 2021
Progress in the Management of Pancreatic Neuroendocrine TumorsAmy Chang, Scott K Sherman, James R Howe, et al.
Neuroscience|November 28, 2002
The expression of dominant-negative subunits selectively suppresses neuronal AMPA and kainate receptorsAntoine Robert, Rhonda Hyde, Thomas E Hughes, et al.
Biophysical Journal|May 30, 2006
The relationship between agonist potency and AMPA receptor kineticsWei Zhang, Antoine Robert, Stine B Vogensen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2005
AMPA receptor binding cleft mutations that alter affinity, efficacy, and recovery from desensitizationAntoine Robert, Neali Armstrong, J Eric Gouaux, et al.
The European Journal of Neuroscience|March 22, 2002
The speeding of EPSC kinetics during maturation of a central synapseMark J Wall, Antoine Robert, James R Howe, et al.
Current Treatment Options in Oncology|October 13, 2025
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine TumorsJeremy Chang, Udhayvir S Grewal, Scott K Sherman, et al.
Hematology/Oncology Clinics of North America|November 7, 2024
Surgical Management of Neuroendocrine Tumor Liver MetastasesCatherine G Tran, Scott K Sherman, Chandrikha Chandrasekharan, et al.
Current Problems in Surgery|May 19, 2005
Hereditary colorectal cancer-part IIAnders Merg, Henry T Lynch, Jane F Lynch, et al.
The Journal of Surgical Research|February 10, 2012
Germline mutations in SMAD4 disrupt bone morphogenetic protein signalingJennifer C Carr, Fadi S Dahdaleh, Donghong Wang, et al.
Pageof 19